Meeting Banner
Abstract #4634

Evaluation of MRS- and MRI- PDFF and Liver Biopsy measure of hepatic fat fraction in a clinically relevant cohort

Christian Simonsson1,2,3, Shan Cai1,2, Jens Tellman1, Markus Karlsson1,4, Gunnar Cedersund2,3, Simone Ignatova5, Patrik Nasr6, Mattias Ekstedt2,6, Stergios Kechagias2,6, Nils Dahlström2,7, and Peter Lundberg1,2
1Department of Radiation Physics, Radiology, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden, 2Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden, 3Department of Biomedical Engineering, Linköping University, Linköping, Sweden, 4AMRA Medical AB, Linköping, Sweden, 5Department of Clinical Pathology and Clinical Genetics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden, 6Department of Gastroenterology and Hepatology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden, 7Department of Radiology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

Synopsis

Keywords: Liver, Liver

Motivation: Metabolic Associated Fatty Liver Disease (MAFLD) will increase the burden on future healthcare. Reliable screening alternatives such as MR-techniques e.g., nP-Dixon imaging and proton MR-spectroscopy are widely used. However, the number of studies comparing both MR-techniques with biopsies in clinically relevant cohorts is limited.

Goal(s): Compare MR Dixon imaging and proton MR-spectroscopy fat fraction with histological evaluation of steatosis

Approach: We have compared three different PDFF measurements; MRS, 6- and 2-point Dixon PDFF, in a prospective study, which included 84 clinically relevant patients with diffuse liver disease.

Results: All three techniques could accurately characterize histology based steatosis scores in this clinically relevant cohort.

Impact: In this prospective study, with a clinically relevant cohort, a difference between MRS and Dixon determined PDFF was measured. Both methods could distinguish between different histological levels of steatosis, and both methods could therefore characterize the patient group accurately.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords